Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus (Q40572101)

21 September 2017

title

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus (English)

1 reference

neuropsychiatric systemic lupus erythematosus

21 September 2017

main subject

0 references

author name string

Neuwelt CM

1

1 reference

21 September 2017

Lacks S

2

1 reference

21 September 2017

Kaye BR

3

1 reference

21 September 2017

Ellman JB

4

1 reference

21 September 2017

Borenstein DG

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

American Journal of Medicine

21 September 2017

published in

1 reference

21 September 2017

volume

98

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

32-41

1 reference

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Central nervous system disease in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

The neurological manifestations of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Nervous system involvement in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Plasmapheresis for lupus nephritis. Lupus Plasmapheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

7 January 2021

Plasmapheresis in lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

inferred from DOI database lookup

7 January 2021

based on heuristic

The natural history of systemic lupus erythematosus by prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980078-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)80078-3

1 reference

release_gfovs6sq6fcqlofvztql6g5haq

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gfovs6sq6fcqlofvztql6g5haq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference